Health ❯Obesity

Obesity Treatment

Fat Conversion Semaglutide Medications Zepbound Medicare Coverage

Diabetes and Obesity Drugs Found to Protect Kidney Health

New research highlights significant kidney and heart benefits of GLP-1 receptor agonists for patients with or without diabetes.

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients

Scientists Convert White Fat Cells to Calorie-Burning Beige Fat

Medicare's Prohibition on New Obesity Drugs Under Fire